Retrospective clinical data is essential in the quest to improve outcomes and contain costs, but even more valuable is integrated, near real-time data analytics that illustrate how you compare to other cardiac care centers nationally.
“It’s good to be able to understand ‘this is how I did’—but that’s really reporting the news,” says LUMEDX analytics consultant Rachanee Curry, FACHE. “It’s better to be able to have real-time feedback and to be able to change your performance, finding opportunities for improvement as you go along.”
However, retrospective and real-time or even prospective analytics can all deliver crucial insights to hospitals. Even data collected for the Society of Thoracic Surgeons (STS) and the American College of Cardiology’s National Cardiovascular Data Registry® (ACC NCDR) can be used to understand service line performance, view outliers and identify root causes. These are the insights that enable improvement.
Rachanee Curry, LUMEDX analytics consultant, talks about the kinds of insights that can enable improved outcomes and reduced costs.
“Being able to focus in on those areas where your program is performing differently than best practices means you can improve the processes of care that lead to these variances and that will invariably lead to improved clinical outcomes,” Curry says.
LUMEDX offers data analytics solutions that enable physicians and service line leaders to monitor, measure, and improve all aspects of cardiovascular services—to help drive performance while reducing costs. LUMEDX is also the No. 1 provider of ACC and STS Registry Software. To learn more, email email@example.com.